Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Polo-like kinase 4 (Plk4) is a key regulator of centriole duplication, an event critical for the maintenance of genomic integrity. We show that Plk4 relocalizes from the inner
Cep192
ring to the outer Cep152 ring as newly recruited Cep152 assembles around the
Cep192
-encircled daughter centriole. Crystal-structure analyses revealed that
Cep192
- and Cep152-derived peptides bind the cryptic polo box (CPB) of Plk4 in opposite orientations and in a mutually exclusive manner. The Cep152 peptide bound to the CPB markedly better than did the
Cep192
peptide and effectively 'snatched' the CPB away from a preformed CPB-
Cep192
peptide complex. A
cancer-associated
Cep152 mutation impairing the Plk4 interaction induced defects in procentriole assembly and chromosome segregation. Thus, Plk4 is intricately regulated in time and space through ordered interactions with two distinct scaffolds,
Cep192
and Cep152, and a failure in this process may lead to human cancer.
...
PMID:Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis. 2499 97